Wikidata

(Q45893794)

English

A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer

scientific article published on 4 November 2015

In more languages

Statements

title
A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4645486
retrieved
17 December 2017
reference URL
http://europepmc.org/abstract/PMC/4645486

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45893794&oldid=2088762110"